The Wuxi International Bioforum 2019 and The 9th Cell Death & Disease Symposium - New Drug Discovery
Internationally renowned leading scientists and pioneers will present cutting-edge advances in cancer immunotherapy, targeted therapy with small molecules,and/or monoclonal antibodies, and novel cell therapeutic strategies. . New challenges, topical directions and novel approacheswill be discussed.
2018 (4th) International Symposium on Next-Generation CAR & TCR-T Cells
Chimeric antigen receptors are engineered receptors that combine a new specificity with an immune cell to target cancer cells. Typically, these receptors graft the specificity of a monoclonal antibody onto a T cell. CAR-T cells are a new type of treatment that uses living cells that have been transformed.
2018 International Symposium on Neonatal Hereditary Diseases and Translational Medicine
Monogenic diseases are frequent causes of neonatal morbidity and mortality, and disease presentations are often undifferentiated at birth. More than 3500 monogenic diseases have been characterized, but clinical testing is available for only some of them and many feature clinical and genetic heterogeneity.
2018 (3rd) International Symposium on Protein Modification and Diseases
Protein Modification refers to the covalent and generally enzymatic modification of proteins following protein biosynthesis, which is of great importance in cell signaling. Modification of proteins can be experimentally detected by a variety of techniques, including mass spectrometry, Eastern blotting, and Western blotting.
2018 International Symposium on Biological and Medical Nanomaterials
New biomedical materials with structure at the nanoscale often have unique optical, electronic, or mechanical properties. Due to their advantages like small sizes and good biocompatibility, nanomaterials are widely used in biological and medical fields.
2018 International Symposium on Metabolomics and Translational Medicine
Metabolomics is the scientific study of chemical processes involving metabolites, the small molelcule intermediates and products of metabolism. Through participating in this symposium, you can learn more about the processing of technologies, the whole industry and the market of metabolomics and disease diagnosis in China!
2018 International Symposium on single-Cell Omics Technology and Application
Recent technological advances are providing unprecedented opportunities to analyse the complexities of biological systems at the single-cell level. Various crucial biological phenomena are either invisible or only partially characterized when interrogated using standard analyses that average data across a bulk population of cells.
2018 (6th) International Symposium on Non-Coding RNA
A non-coding RNA (ncRNA) is an RNA molecule that is not translated into a protein. Non-coding RNAs contribute to diseases including cancer, autism, and Alzheimer's.
2018 Symposium on Digital Pathology and Clinical Application
With the advent of Whole-Slide Imaging, the field of digital pathology has exploded and is currently regarded as one of the most promising avenues of diagnostic medicine in order to achieve even better, faster and cheaper diagnosis, prognosis and prediction of cancer and other important diseases.
2018 Symposium on Cancer Evolution and Heterogeneity
Heterogeneity is a major challenge in cancer treatment, which has a profound impact on cancer evolution & metastasis and drug resistance. With the developments of new technologies, there emerge successive achievements with great significance on clinical therapeutics. This symposium will focus on cancer heterogeneity, promoting the clinical translation of research.